TipRanks
Go Ultimate55% OFF

Matthew Perraton Insider Profile

4 Followers

Matthew Perraton, Director at Theralase Technologies, holds 163.00K shares in Theralase Technologies (Ticker: TSE:TLT). Most recently, Matthew Perraton Bought 11,000 shares of Theralase Technologies on May 21, 2026 for an estimated value of C$2.64K.

Matthew Perraton's Trading History

TLT
Theralase Technologies
May 21, 2026DirectorInformative Buy2.64KC$29.34K
TSE:TLT
Insider Shares: 163.00K (6.34%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 21, 2026Informative BuyC$2.64K11,000C$0.24-21.70%―
Apr 13, 2026Informative BuyC$2.60K10,000C$0.26-42.80%―
Jun 18, 2025Informative BuyC$10.22K51,100C$0.20+27.70%―
Mar 13, 2025Informative BuyC$12.00K40,000C$0.30+26.10%―
Feb 09, 2024Informative BuyC$9.00K50,000C$0.18+31.70%―

You May Also Like

Matthew Perraton insider profile FAQ

What is the percentage of profitable transactions made by Matthew Perraton?
The percentage of profitable transactions made by Matthew Perraton is 29%.
What is the average return per transaction made by Matthew Perraton?
The average return per transaction made by Matthew Perraton is 0.20%.
What stocks does Matthew Perraton hold?
Matthew Perraton holds: TSE:TLT stocks.
What was Matthew Perraton’s latest transaction?
Matthew Perraton’s latest transaction was an Informative Buy of C$2.64K.
What was Matthew Perraton's most profitable transaction?
Matthew Perraton’s most profitable transaction was an Informative Buy of TSE:TLT stock on February 9, 2024. The return on the trade was 31.70%.
What is Matthew Perraton's role in Theralase Technologies?
Matthew Perraton's role in Theralase Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.